Classification
Product TypeIngredient
Product FormBulk powder (vitamin ingredient / premix input)
Industry PositionNutraceutical ingredient (dietary supplement input)
Market
Vitamin B7 (biotin) in India is primarily positioned as a vitamin ingredient used in health supplements and nutraceutical products regulated under FSSAI’s 2016 framework (compendium version 29.09.2021), where biotin is listed as D-biotin in Schedule I. The same framework links vitamin levels to recommended daily allowance (ICMR) and recognizes pharmacopeial quality benchmarks for common supplement dosage forms (tablets, capsules, syrups). As a result, India functions mainly as a domestic formulation and consumption market supplied through nutrient-ingredient and premix channels, with notable reliance on imported vitamins in the broader HS 2936 category (UN Comtrade-derived reporting shows China as the largest supplier for HS 2936 imports to India in 2023). For imports, market access and continuity are sensitive to FSSAI Food Import Clearance System (FICS) requirements and document-driven clearance steps integrated with Customs ICEGATE under SWIFT.
Market RoleImport-reliant nutraceutical ingredient market with strong domestic supplement formulation base
Domestic RoleInput vitamin used to formulate health supplements/nutraceutical dosage forms (e.g., capsules, tablets, syrups) for the domestic market
Market GrowthNot Mentioned
Risks
Regulatory Compliance HighFor vitamin B7 (biotin) used in supplements in India, non-compliance with FSSAI’s Health Supplements/Nutraceuticals framework (e.g., ingredient not aligned to permitted schedules, or formulation levels not aligned to applicable RDA/standards) can trigger import clearance delays, non-clearance decisions, or downstream enforcement risk for finished products.Map the ingredient (biotin as D-biotin) and intended finished-product category to the relevant FSSAI schedules, and run a pre-shipment dossier check (label/ingredient list + compliance rationale) before import.
Documentation Gap MediumFSSAI import clearance via FICS is document-intensive (e.g., Bill of Entry, COO, ingredient list, product label). Any mismatch or omission can cause holds, additional queries, or clearance delays that interrupt manufacturing continuity for supplement producers.Use a standardized FICS document checklist aligned to the shipment pack (BoE/COO/BOL/invoice/packing list/ingredient list/label) and reconcile fields (product name, batch, origin, net weight) across documents before filing.
Supply Concentration MediumIndia’s imports for the broader vitamins heading (HS 2936) show supplier concentration (UN Comtrade-derived reporting for 2023 indicates China as the largest supplier), creating exposure to origin-specific disruptions, price volatility, or trade friction that can affect availability of vitamin ingredients including biotin.Qualify multiple origins/suppliers for biotin, maintain safety stock for critical SKUs, and pre-approve alternates in formulations where feasible.
Food Safety MediumFinished supplement formats are expected to meet recognized quality benchmarks (pharmacopeial references are recognized in the FSSAI framework for common dosage forms). Ingredient quality variability or inadequate quality documentation can increase the risk of rejection during testing/scrutiny or downstream quality incidents.Require batch COA and third-party testing against the intended quality benchmarks, and ensure full traceable documentation for each batch used in premixes/finished products.
FAQ
Is biotin (vitamin B7) recognized as a permitted vitamin ingredient for health supplements/nutraceuticals in India?Yes. In FSSAI’s Health Supplements/Nutraceuticals regulatory framework (compendium version 29.09.2021), biotin is listed in Schedule I as 'Biotin (D-biotin)'.
What documents are commonly required to file a food import clearance application in India’s FSSAI system for supplement-related products?FSSAI’s Food Imports Manual lists core documents used for FICS filing such as Bill of Entry, Country of Origin Certificate, Bill of Lading, FSSAI Import License, invoice, packing list, ingredient list, and product label (and the importer must also have a valid IEC issued by DGFT).
Which pharmacopeial quality standards can be referenced for common supplement dosage forms under India’s FSSAI nutraceutical framework?FSSAI’s nutraceutical framework references Indian Pharmacopoeia, British Pharmacopoeia, and United States Pharmacopeia general quality requirements for common dosage forms like tablets, capsules, and syrups.